National and Kapodistrian University of Athens
In vivo και in vitro εκτίμηση της καθίζησης λιπόφιλων ασθενών βάσεων και του υπερκορεσμού των περιεχομένων του αυλού του λεπτού εντέρου υγιών εν...
Abstract
dc:descriptionPurpose: To evaluate precipitation in and supersaturation of intestinal contents, after administration of pharmacologically relevant doses of dipyridamole and ketoconazole to twelve fasted healthy adults. Τo develop an in vitro methodology for prediction of concentrations and potential precipitation of highly permeable, lipophilic weak bases in fasted upper small intestine, based on luminal dipyridamole and ketoconazole data. To evaluate the usefulness of the in vitro methodology in predicting precipitation in fasted upper small intestine of two highly permeable, lipophilic weak bases under development, AZD0865 and SB705498, based on plasma data. Methods: On two separate days each subject was administered in stomach 240 mL aqueous solutions of two dipyridamole doses (30 mg and 90 mg) and two ketoconazole doses (100 mg and 300 mg). Physicochemical characteristics, total drug content, and drug concentration were measured in individual intestinal contents (≤7 mL) aspirated at specific times post-dosing. Drug concentration after incubation (37.C/48h) of the relevant supernatants and equilibrium solubility were also measured. For the in vitro experiments, a three-compartment setup was used. Depending on the dosage form administered in the human study, a solution or a suspension was placed in gastric compartment. A solution simulating the luminal environment (FaSSIF-V2plus) was initially placed in duodenal compartment. Concentrated FaSSIF-V2plus was placed in reservoir compartment in order to keep constant the physicochemical characteristics of the solution in the duodenal compartment during the experiment. Total drug content and drug concentration were measured in samples collected at specific time intervals. Also, drug concentration after incubation (37.C/48h) of the relevant filtrates and equilibrium solubility were measured. In both human and in vitro studies crystallinity of precipitates was evaluated with X-rays. Results: Intraluminal precipitated fraction was minimal (dipyridamole, ≤7 %) or limited (ketoconazole, ≤16 %). Ketoconazole precipitates were mostly amorphous. Depending on dose, intestinal contents with pH>3.6 were supersaturated with dipyridamole up to 10 min (low dose) and 30 min (high dose), and with ketoconazole up to 30 min (low dose) and 50 min (high dose) post-administration. Intestinal contents with pH>5 and concentration of micellar components <5 mM were supersaturated with dipyridamole or ketoconazole but precipitated fraction was significant only for ketoconazole. After incubation, crystalline precipitates were found in almost all samples. Slow precipitation of base and/or precipitation of other phases account for this observation. In vitro dipyridamole and ketoconazole concentrations and precipitated fractions adequately reflected luminal data. However, unlike luminal precipitates, in vitro ketoconazole precipitates were crystalline. In vitro AZD0865 data confirmed previously published human pharmacokinetic data suggesting that absorption rates are not affected by luminal precipitation. In vitro SB705498 data predicted that significant luminal precipitation occurs after a 100 mg or 400 mg but not after a 10 mg dose, consistent with human pharmacokinetic data. Conclusions: Intraluminal precipitation of weakly alkaline, lipophilic, slightly soluble, highly permeable drugs may not be substantial. Estimating intestinal supersaturation in regard to free base is inadequate as other phases may precipitate. An in vitro methodology for predicting concentrations and potential precipitation of slightly soluble, highly permeable, lipophilic weak bases in fasted upper small intestine was developed and evaluated for its predictability in regard to luminal precipitation in humans.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2012
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Ψαχούλιας, Δημήτριος
- Psachoulias, Dimitrios
Subjects
dc:subject × 16Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/28030